Amazon is already one of the largest companies on the planet. But could its stock (AMZN) be poised to outpace the market for ...

As the stock continues to attract attention, experts urge caution, warning that such rallies are often short-lived and could leave unsuspecting investors facing steep losses ...

Wells Fargo’s Series Z preferred shares promise steady returns. Read why WFC stock is positioned for a high single-digit or ...

Biogen’s disappointing Leqembi performance and weak pipeline hurt future growth. Learn why BIIB stock is rated "sell" due to ...

Shopkeepers on middle-class high streets are tying down their goods amid a shoplifting epidemic ...

Novo Nordisk (NVO) stock took a hit this week, after a Super Bowl ad highlighted a growing challenge to the company’s ...

Nasal vaccine devices have the potential to offer more convenient and more effective protection against a variety of viruses.

Hims & Hers wants to keep on selling a compounded version of Ozempic. And it's channeling anti-establishment vibes to make its case.

Nagaraj Shetti, Technical Research Analyst at HDFC Securities, believes Monday's pattern could be considered as a High Wave, ...

Natco Pharma(Rs. 310.80 crore), HDFC Bank(Rs. 292.11 crore), Manappuram Finance(Rs. 278.16 crore), Mazagon Dock Ship(Rs.

ASX health stocks have fallen this week as Chemist Warehouse hits the bourse through its merger with Sigma Healthcare.

Telehealth stock Hims & Hers (HIMS) spiked more than 24% in trading Thursday, days after its Super Bowl ad promoting cheaper ...